PT  - JOURNAL ARTICLE
AU  - Nichols, Emma Hitt
ED  - Birnie, David
TI  - Continued Warfarin Better than Heparin Bridging during Device Implantation
DP  - 2013 Jul 01
TA  - MD Conference Express
PG  - 10--10
VI  - 13
IP  - 3
4099  - http://mdc.sagepub.com/content/13/3/10.short
4100  - http://mdc.sagepub.com/content/13/3/10.full
AB  - Importantly, up to 35% of patients that undergo arrhythmic device implantation also require chronic anticoagulant treatment. Current clinical practice guidelines recommend discontinuing warfarin treatment prior to surgery and treating patients with low-molecular-weight heparin [Douketis JD et al. Chest 2012]. This article presents data from the Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial [BRUISE CONTROL; Birnie D et al. N Engl J Med 2013], which tested the hypothesis that continued treatment with warfarin would reduce the number of device-pocket hematomas without increasing the risk of major perioperative bleeding events.